IL33 and Alzheimer disease: Together, our findings identify AHR signaling as a central pathway by which skin commensals, via MVs and tryptophan-derived metabolites such as indole-3-aldehyde, enhance barrier function, suppress IL-33-driven inflammation and limit S. aureus colonization, a protective axis that appears diminished in AD (see Graphical Abstract).